Search

Background: The expression profiles of solid tumor models in rodents have been only minimally studied despite their extensive use to develop anticancer agents. We have applied RNA expression profiling using Affymetrix U95A GeneChips to address fundamental biological questions about human tumor lines. Methods: To determine whether gene expression changed significantly as a tumor increased in size, we analyzed samples from two human colon carcinoma lines (Colo205 and HCT-116) at three different sizes (200 mg, 500 mg and 1000 mg). To investigate whether gene expression was influenced by the strain of mouse, tumor samples isolated from C.B-17 SCID and Nu/Nu mice were also compared. Finally, the gene expression differences between tissue culture and in vivo samples were investigated by comparing profiles from lines grown in both environments. Results: Multidimensional scaling and analysis of variance demonstrated that the tumor lines were dramatically different from each other and that gene expression remained constant as the tumors increased in size. Statistical analysis revealed that 63 genes were differentially expressed due to the strain of mouse the tumor was grown in but the function of the encoded proteins did not link to any distinct biological pathways. Hierarchical clustering of tissue culture and xenograft samples demonstrated that for each individual tumor line, the in vivo and in vitro profiles were more similar to each other than any other profile. We identified 36 genes with a pattern of high expression in xenograft samples that encoded proteins involved in extracellular matrix, cell surface receptors and transcription factors. An additional 17 genes were identified with a pattern of high expression in tissue culture samples and encoded proteins involved in cell division, cell cycle and RNA production. Conclusions: The environment a tumor line is grown in can have a significant effect on gene expression but tumor size has little or no effect for subcutaneously grown solid tumors. Furthermore, an individual tumor line has an RNA expression pattern that clearly defines it from other lines even when grown in different environments. This could be used as a quality control tool for preclinical oncology studies. [ABSTRACT FROM AUTHOR]

Background: Molecular characterization has contributed to the understanding of the inception, progression, treatment and prognosis of cancer. Nucleic acid array-based technologies extend molecular characterization of tumors to thousands of gene products. To effectively discriminate between tumor sub-types, reliable laboratory techniques and analytic methods are required. Results: We derived mRNA expression profiles from 21 human tissue samples (eight normal kidneys and 13 kidney tumors) and two pooled samples using the Affymetrix GeneChip platform. A panel of ten clustering algorithms combined with four data pre-processing methods identified a consensus cluster dendrogram in 18 of 40 analyses and of these 16 used a logarithmic transformation. Within the consensus dendrogram the expression profiles of the samples grouped according to tissue type; clear cell and chromophobe carcinomas displayed distinctly different gene expression patterns. By using a rigorous statistical selection based method we identified 355 genes that showed significant (p < 0.001) gene expression changes in clear cell renal carcinomas compared to normal kidney. These genes were classified with a tool to conceptualize expression patterns called "Functional Taxonomy". Each tumor type had a distinct "signature," with a high number of genes in the categories of Metabolism, Signal Transduction, and Cellular and Matrix Organization and Adhesion. Conclusions: Affymetrix GeneChip profiling differentiated clear cell and chromophobe carcinomas from one another and from normal kidney cortex. Clustering methods that used logarithmic transformation of data sets produced dendrograms consistent with the sample biology. Functional taxonomy provided a practical approach to the interpretation of gene expression data. [ABSTRACT FROM AUTHOR]

Describes the synthesis of methyl 5-amino-1(chloromethyl)-3[(5,6,7-trimethoxyindol-2-yl)carbonyl]-1,2-dihydro-3H-pyrrolo[3,2-elindole-7-carboxylate, an amino analogue of the anticancer antibiotic and potent minor groove alkylating agent seco-duocarmycin SA. Sequential radical cyclization and Hemetsberger reaction; DNA alkylation.

To evaluate thermal nociceptive thresholds (TNTs) before and after inducing a standardized radiocarpal bone osteochondral fracture (OCF) in horses. Prospective, controlled, randomized, masked study. A group of 10 Thoroughbred fillies aged 2 years. Skin temperature and TNTs were measured on the skin over the triceps brachii muscle in both the thoracic limbs before (week 0) and weekly (weeks 1–8) after unilateral arthroscopic induction of a radiocarpal OCF (n = 4) or sham surgery (n = 6) followed by a standardized exercise programme. The contralateral, non-operated thoracic limb was used as a control within each horse. Percentage thermal excursion (%TE) defined as %TE = 100 ∗ (TNT – skin temperature)/(cut-off temperature – skin temperature) was calculated. Data were analysed with a mixed-effects model followed by Dunnett's and Tukey's tests for within and between-limbs comparisons, respectively; p < 0.05 was considered significant. Skin temperature in the control limb of OCF horses was significantly higher at week 7 than at week 0 (p = 0.0125). At week 1, TNTs and %TE values in operated limbs of OCF horses were significantly reduced compared with their baseline values at week 0 (p ≤ 0.0153) and their values in contralateral control limbs (p ≤ 0.0024) and operated limbs of sham-operated horses (p ≤ 0.0162). At week 2, TNTs and %TE values in operated limbs of OCF horses remained significantly reduced compared with values in operated limbs of sham-operated horses (p ≤ 0.0248). Creation of an OCF in a radiocarpal bone induced transitory (<2 weeks) ipsilateral heat hypersensitivity proximal to the surgery site (skin over the triceps brachii muscle) in horses. Surgically induced OCF may cause somatosensory abnormalities consistent with secondary thermal hyperalgesia. [ABSTRACT FROM AUTHOR]

Objective To compare the thermal nociceptive thresholds (TNTs) of dogs from three working/ sport breeds. Study design Experimental prospective study. Animals Thirty healthy adult dogs of mixed age, sex and reproductive status, 10 of each of three breeds: Harrier Hound, Greyhound and New Zealand Huntaway. Methods On one day of each week for 4 weeks, unrestrained dogs were tested six times. TNTs were measured using a remotely activated device comprising a thermode attached to the thoracic limb, controlled by a microprocessor attached to the animal. Latency to exhibit behaviour indicative of nociception after initiation of heating and the temperature of the thermode at the point of behavioural response were measured. Linear mixed-effects models were fitted to the data, with dog included as a randomeffect, initial thermode temperature as a covariate and day, week and breed as fixed effects. Results Initial thermode temperature significantly affected dogs' latency to respond (p < 0.001). Breed had a significant effect on both latency to respond and response temperature. Huntaways took longer to respond than Harriers or Greyhounds. For example, when the initial thermode temperature was 30 C, Huntaways took 39.0 seconds to respond compared with 35.8 seconds for Harriers and 36.8 seconds for Greyhounds. Huntaways also responded at higher temperatures (mean ± standard deviation: Huntaways 49.7 ± 1.3 C, Harriers 48.4 ±1.6 ° and Greyhounds 48.7 ± 1.6 C). Conclusions and clinical relevance Huntaways appeared to be less sensitive to thermal pain than the other breeds. Such information could be used by researchers and clinicians to better understand the generalizability of data gathered from a specific breed to the wider canine population or to tailor more effective pharmacological approaches to pain management in dogs. [ABSTRACT FROM AUTHOR]